Cargando…
An engineered CRISPR-Cas12a variant and DNA-RNA hybrid guides enable robust and rapid COVID-19 testing
Extensive testing is essential to break the transmission of SARS-CoV-2, which causes the ongoing COVID-19 pandemic. Here, we present a CRISPR-based diagnostic assay that is robust to viral genome mutations and temperature, produces results fast, can be applied directly on nasopharyngeal (NP) specime...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979722/ https://www.ncbi.nlm.nih.gov/pubmed/33741959 http://dx.doi.org/10.1038/s41467-021-21996-6 |
_version_ | 1783667322187153408 |
---|---|
author | Ooi, Kean Hean Liu, Mengying Mandy Tay, Jie Wen Douglas Teo, Seok Yee Kaewsapsak, Pornchai Jin, Shengyang Lee, Chun Kiat Hou, Jingwen Maurer-Stroh, Sebastian Lin, Weisi Yan, Benedict Yan, Gabriel Gao, Yong-Gui Tan, Meng How |
author_facet | Ooi, Kean Hean Liu, Mengying Mandy Tay, Jie Wen Douglas Teo, Seok Yee Kaewsapsak, Pornchai Jin, Shengyang Lee, Chun Kiat Hou, Jingwen Maurer-Stroh, Sebastian Lin, Weisi Yan, Benedict Yan, Gabriel Gao, Yong-Gui Tan, Meng How |
author_sort | Ooi, Kean Hean |
collection | PubMed |
description | Extensive testing is essential to break the transmission of SARS-CoV-2, which causes the ongoing COVID-19 pandemic. Here, we present a CRISPR-based diagnostic assay that is robust to viral genome mutations and temperature, produces results fast, can be applied directly on nasopharyngeal (NP) specimens without RNA purification, and incorporates a human internal control within the same reaction. Specifically, we show that the use of an engineered AsCas12a enzyme enables detection of wildtype and mutated SARS-CoV-2 and allows us to perform the detection step with loop-mediated isothermal amplification (LAMP) at 60-65 °C. We also find that the use of hybrid DNA-RNA guides increases the rate of reaction, enabling our test to be completed within 30 minutes. Utilizing clinical samples from 72 patients with COVID-19 infection and 57 healthy individuals, we demonstrate that our test exhibits a specificity and positive predictive value of 100% with a sensitivity of 50 and 1000 copies per reaction (or 2 and 40 copies per microliter) for purified RNA samples and unpurified NP specimens respectively. |
format | Online Article Text |
id | pubmed-7979722 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-79797222021-04-16 An engineered CRISPR-Cas12a variant and DNA-RNA hybrid guides enable robust and rapid COVID-19 testing Ooi, Kean Hean Liu, Mengying Mandy Tay, Jie Wen Douglas Teo, Seok Yee Kaewsapsak, Pornchai Jin, Shengyang Lee, Chun Kiat Hou, Jingwen Maurer-Stroh, Sebastian Lin, Weisi Yan, Benedict Yan, Gabriel Gao, Yong-Gui Tan, Meng How Nat Commun Article Extensive testing is essential to break the transmission of SARS-CoV-2, which causes the ongoing COVID-19 pandemic. Here, we present a CRISPR-based diagnostic assay that is robust to viral genome mutations and temperature, produces results fast, can be applied directly on nasopharyngeal (NP) specimens without RNA purification, and incorporates a human internal control within the same reaction. Specifically, we show that the use of an engineered AsCas12a enzyme enables detection of wildtype and mutated SARS-CoV-2 and allows us to perform the detection step with loop-mediated isothermal amplification (LAMP) at 60-65 °C. We also find that the use of hybrid DNA-RNA guides increases the rate of reaction, enabling our test to be completed within 30 minutes. Utilizing clinical samples from 72 patients with COVID-19 infection and 57 healthy individuals, we demonstrate that our test exhibits a specificity and positive predictive value of 100% with a sensitivity of 50 and 1000 copies per reaction (or 2 and 40 copies per microliter) for purified RNA samples and unpurified NP specimens respectively. Nature Publishing Group UK 2021-03-19 /pmc/articles/PMC7979722/ /pubmed/33741959 http://dx.doi.org/10.1038/s41467-021-21996-6 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Ooi, Kean Hean Liu, Mengying Mandy Tay, Jie Wen Douglas Teo, Seok Yee Kaewsapsak, Pornchai Jin, Shengyang Lee, Chun Kiat Hou, Jingwen Maurer-Stroh, Sebastian Lin, Weisi Yan, Benedict Yan, Gabriel Gao, Yong-Gui Tan, Meng How An engineered CRISPR-Cas12a variant and DNA-RNA hybrid guides enable robust and rapid COVID-19 testing |
title | An engineered CRISPR-Cas12a variant and DNA-RNA hybrid guides enable robust and rapid COVID-19 testing |
title_full | An engineered CRISPR-Cas12a variant and DNA-RNA hybrid guides enable robust and rapid COVID-19 testing |
title_fullStr | An engineered CRISPR-Cas12a variant and DNA-RNA hybrid guides enable robust and rapid COVID-19 testing |
title_full_unstemmed | An engineered CRISPR-Cas12a variant and DNA-RNA hybrid guides enable robust and rapid COVID-19 testing |
title_short | An engineered CRISPR-Cas12a variant and DNA-RNA hybrid guides enable robust and rapid COVID-19 testing |
title_sort | engineered crispr-cas12a variant and dna-rna hybrid guides enable robust and rapid covid-19 testing |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979722/ https://www.ncbi.nlm.nih.gov/pubmed/33741959 http://dx.doi.org/10.1038/s41467-021-21996-6 |
work_keys_str_mv | AT ooikeanhean anengineeredcrisprcas12avariantanddnarnahybridguidesenablerobustandrapidcovid19testing AT liumengyingmandy anengineeredcrisprcas12avariantanddnarnahybridguidesenablerobustandrapidcovid19testing AT tayjiewendouglas anengineeredcrisprcas12avariantanddnarnahybridguidesenablerobustandrapidcovid19testing AT teoseokyee anengineeredcrisprcas12avariantanddnarnahybridguidesenablerobustandrapidcovid19testing AT kaewsapsakpornchai anengineeredcrisprcas12avariantanddnarnahybridguidesenablerobustandrapidcovid19testing AT jinshengyang anengineeredcrisprcas12avariantanddnarnahybridguidesenablerobustandrapidcovid19testing AT leechunkiat anengineeredcrisprcas12avariantanddnarnahybridguidesenablerobustandrapidcovid19testing AT houjingwen anengineeredcrisprcas12avariantanddnarnahybridguidesenablerobustandrapidcovid19testing AT maurerstrohsebastian anengineeredcrisprcas12avariantanddnarnahybridguidesenablerobustandrapidcovid19testing AT linweisi anengineeredcrisprcas12avariantanddnarnahybridguidesenablerobustandrapidcovid19testing AT yanbenedict anengineeredcrisprcas12avariantanddnarnahybridguidesenablerobustandrapidcovid19testing AT yangabriel anengineeredcrisprcas12avariantanddnarnahybridguidesenablerobustandrapidcovid19testing AT gaoyonggui anengineeredcrisprcas12avariantanddnarnahybridguidesenablerobustandrapidcovid19testing AT tanmenghow anengineeredcrisprcas12avariantanddnarnahybridguidesenablerobustandrapidcovid19testing AT ooikeanhean engineeredcrisprcas12avariantanddnarnahybridguidesenablerobustandrapidcovid19testing AT liumengyingmandy engineeredcrisprcas12avariantanddnarnahybridguidesenablerobustandrapidcovid19testing AT tayjiewendouglas engineeredcrisprcas12avariantanddnarnahybridguidesenablerobustandrapidcovid19testing AT teoseokyee engineeredcrisprcas12avariantanddnarnahybridguidesenablerobustandrapidcovid19testing AT kaewsapsakpornchai engineeredcrisprcas12avariantanddnarnahybridguidesenablerobustandrapidcovid19testing AT jinshengyang engineeredcrisprcas12avariantanddnarnahybridguidesenablerobustandrapidcovid19testing AT leechunkiat engineeredcrisprcas12avariantanddnarnahybridguidesenablerobustandrapidcovid19testing AT houjingwen engineeredcrisprcas12avariantanddnarnahybridguidesenablerobustandrapidcovid19testing AT maurerstrohsebastian engineeredcrisprcas12avariantanddnarnahybridguidesenablerobustandrapidcovid19testing AT linweisi engineeredcrisprcas12avariantanddnarnahybridguidesenablerobustandrapidcovid19testing AT yanbenedict engineeredcrisprcas12avariantanddnarnahybridguidesenablerobustandrapidcovid19testing AT yangabriel engineeredcrisprcas12avariantanddnarnahybridguidesenablerobustandrapidcovid19testing AT gaoyonggui engineeredcrisprcas12avariantanddnarnahybridguidesenablerobustandrapidcovid19testing AT tanmenghow engineeredcrisprcas12avariantanddnarnahybridguidesenablerobustandrapidcovid19testing |